UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
WuXi PharmaTech (Cayman) Inc.
| (Name of Issuer) |
Ordinary Shares*
American Depositary Shares
| (Title of Class of Securities) |
929352102**
| (CUSIP Number) |
December 31, 2007
| (Date of Event Which Requires Filing of this Statement) |
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
¨ Rule 13d-1(c)
x Rule 13d-1(d)
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
| * | Not for trading, but only in connection with the registration of American Depositary Shares each representing 8 ordinary shares. |
| ** | This CUSIP applies to the American Depositary Shares. |
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 929352102 | SCHEDULE 13G | Page 2 of 8 Pages |
| 1 | NAMES OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
United Overseas Bank Limited |
|||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
|||
| 3 | SEC USE ONLY
|
|||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Singapore |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5 SOLE VOTING POWER
63,604,4001 | |
| 6 SHARED VOTING POWER
0 | ||
| 7 SOLE DISPOSITIVE POWER
63,604,4002 | ||
| 8 SHARED DISPOSITIVE POWER
0 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
63,604,400 |
|||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
| ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
12.9%3 |
|||
| 12 | TYPE OF REPORTING PERSON*
CO |
| 1 |
Includes (i) 34,453,450 ordinary shares held of record by UOB Hermes Asia Technology Fund (“UOB Hermes”); (ii) 17,015,350 ordinary shares held of record by UOB JAIC Venture Bio Investments Limited (“UOB JAIC”); and (iii) 12,135,600 ordinary shares held of record by UOB Venture Technology Investments Ltd. (“UOB Venture”). United Overseas Bank Limited is an investor in each of UOB Hermes and UOB JAIC through its subsidiary, UOB Capital Investments Pte Ltd and is a direct investor in UOB Venture. United Overseas Bank Limited is the ultimate controlling shareholder of each entity. |
| 2 |
See footnote 1 above. |
| 3 |
Based on 492,226,776 outstanding ordinary shares as of December 31, 2007. |
| CUSIP No. 929352102 | SCHEDULE 13G | Page 3 of 8 Pages |
| 1 | NAMES OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
UOB Capital Investments Pte Ltd |
|||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
|||
| 3 | SEC USE ONLY
|
|||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Singapore |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5 SOLE VOTING POWER
51,468,8004 | |
| 6 SHARED VOTING POWER
0 | ||
| 7 SOLE DISPOSITIVE POWER
51,468,8005 | ||
| 8 SHARED DISPOSITIVE POWER
0 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
51,468,800 |
|||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
| ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
10.5%6 |
|||
| 12 | TYPE OF REPORTING PERSON*
CO |
| 4 |
Includes (i) 34,453,450 ordinary shares held of record by UOB Hermes; and (ii) 17,015,350 ordinary shares held of record by UOB JAIC. UOB Capital Investments Pte Ltd is the direct investor in both UOB Hermes and UOB JAIC, and is the wholly-owned subsidiary of United Overseas Bank Limited. |
| 5 |
See footnote 4 above. |
| 6 |
Based on 492,226,776 outstanding ordinary shares as of December 31, 2007. |
| CUSIP No. 929352102 | SCHEDULE 13G | Page 4 of 8 Pages |
| 1 | NAMES OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
UOB Hermes Asia Technology Fund |
|||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ¨ (b) x |
|||
| 3 | SEC USE ONLY
|
|||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands |
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5 SOLE VOTING POWER
34,453,450 | |
| 6 SHARED VOTING POWER
0 | ||
| 7 SOLE DISPOSITIVE POWER
34,453,450 | ||
| 8 SHARED DISPOSITIVE POWER
0 |
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
34,453,450 |
|||
| 10 | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
¨
| ||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
7.0%7 |
|||
| 12 | TYPE OF REPORTING PERSON*
CO |
| 7 |
Based on 492,226,776 outstanding ordinary shares as of December 31, 2007. |
| CUSIP No. 929352102 | SCHEDULE 13G | Page 5 of 8 Pages |
| Item 1 | (a) |
Name of Issuer: | ||||||||||
| WuXi Pharmatech (Cayman) Inc. (“Issuer”) | ||||||||||||
| Item 1 | (b) |
Address of Issuer’s Principal Executive Offices: | ||||||||||
| 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, People’s Republic of China | ||||||||||||
| Item 2 | (a) |
Name of Person Filing: | ||||||||||
| United Overseas Bank Limited | ||||||||||||
| UOB Capital Investments Pte Ltd | ||||||||||||
| UOB Hermes Asia Technology Fund | ||||||||||||
| Item 2 | (b) |
Address of Principal Business Office or, If None, Residence; Citizenship | ||||||||||
| United Overseas Bank Limited c/o UOB Venture Management Pte Ltd 80 Raffles Place #30-20 UOB Plaza 2 Singapore, 048624 |
||||||||||||
| UOB Capital Investments Pte Ltd c/o UOB Venture Management Pte Ltd 80 Raffles Place #30-20 UOB Plaza 2 Singapore, 048624 |
||||||||||||
| UOB Hermes Asia Technology Fund c/o UOB Venture Management Pte Ltd 80 Raffles Place #30-20 UOB Plaza 2 Singapore, 048624 |
||||||||||||
| Item 2 | (c) |
Citizenship | ||||||||||
| United Overseas Bank Limited - Singapore | ||||||||||||
| UOB Capital Investments Pte Ltd - Singapore | ||||||||||||
| UOB Hermes Asia Technology Fund - Cayman Islands | ||||||||||||
| Item 2 | (d) | Title of Class of Securities: | ||||||||||
| Ordinary shares, par value US$0.02 | ||||||||||||
| American Depositary Shares | ||||||||||||
| Item 2 | (e) | CUSIP Number: | ||||||||||
| 929352102 | ||||||||||||
| Item 3. | Statement Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c): | |||||||||||
| Not applicable. | ||||||||||||
| CUSIP No. 929352102 | SCHEDULE 13G | Page 6 of 8 Pages |
| Item 4. | Ownership | |||||||||
| (a) | Amount Beneficially Owned: | |||||||||
| Reporting Person |
Amount beneficially owned: |
Percent of class: |
Sole power to vote or direct the vote: |
Shared power to vote or to direct the vote: |
Sole power to dispose or to direct the disposition of: |
Shared power to dispose or to direct the disposition of: | |||||||
| United Overseas Bank Limited |
63,604,400 ordinary shares |
12.9 | % | 63,604,400 ordinary shares |
0 | 63,604,400 ordinary shares |
0 | ||||||
| UOB Capital Investments Pte Ltd |
51,468,800 ordinary shares |
10.5 | % | 51,468,800 ordinary shares |
0 | 51,468,800 ordinary shares |
0 | ||||||
| UOB Hermes Asia Technology Fund |
34,453,450 ordinary |
7.0 | % | 34,453,450 ordinary |
0 | 34,453,450 ordinary |
0 | ||||||
| Item 5. | Ownership of Five Percent or Less of a Class | |||||||||
| Not applicable. | ||||||||||
| Item 6. | Ownership of More Than Five Percent on Behalf of Another Person | |||||||||
| Not applicable. | ||||||||||
| Item 7. | Identification and Classification of Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person | |||||||||
| Not applicable. | ||||||||||
| Item 8. | Identification and Classification of Members of the Group | |||||||||
| Not applicable. | ||||||||||
| Item 9. | Notice of Dissolution of Group | |||||||||
| Not applicable. | ||||||||||
| Item 10. | Certifications | |||||||||
| Not applicable. | ||||||||||
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. In addition, by signing below, the undersigned agrees that this Schedule 13G may be filed jointly on behalf of each of the Reporting Persons.
Dated: February 12, 2008
| UNITED OVERSEAS BANK LIMITED | ||
| By: | /s/ Wee Ee Cheong | |
| Name: | Wee Ee Cheong | |
| Title: | Director | |
| UOB CAPITAL INVESTMENTS PTE LTD | ||
| By: | /s/ Tay Tong Poh | |
| Name: | Tay Tong Poh | |
| Title: | Director | |
| UOB HERMES ASIA TECHNOLOGY FUND | ||
| By: | UOB Venture Management Pte Ltd, its investment advisor | |
| By: | /s/ Seah Kian Wee | |
| Name: | Seah Kian Wee | |
| Title: | Managing Director | |
LIST OF EXHIBITS
| Exhibit No. |
Description | |
| A | Joint Filing Agreement |